Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | NPC1L1 | Q9UHC9 | 8/20 | 0.31 |
| ▸ | F2 | P00734 | 1/20 | 0.30 |
| ▸ | REN | P00797 | 1/20 | 0.30 |
| ▸ | CTSD | P07339 | 1/20 | 0.30 |
| ▸ | CTSE | P14091 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7049734 | 0.86 | NAMPT (0.37) | CNR1CNR2NPC1L1F2 | |
| Acetic Acid SCHEMBL6477043 | 0.80 | NPC1L1 (0.32) | NPC1L1F2LMNA | |
| SCHEMBL7049587 | 0.79 | F2 (0.33) | NPC1L1F2LMNA | |
| SCHEMBL7045257 | 0.70 | DPP4 (0.37) | — | |
| SCHEMBL7705663 | 0.69 | OPRM1 (0.32) | NPC1L1F2 | |
| SCHEMBL7049735 | 0.69 | F2 (0.40) | CNR1CNR2F2TP53 | |
| SCHEMBL6477050 | 0.68 | ALDH1A1 (0.38) | RENCTSDLMNA | |
| SCHEMBL6477218 | 0.68 | OPRK1 (0.33) | — | |
| SCHEMBL6487727 | 0.68 | F2 (0.36) | F2LMNA | |
| SCHEMBL6486760 | 0.68 | PRSS1 (0.38) | F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0773955-B1 | NEW THROMBIN INHIBITORS, THEIR PREPARATION AND USE | BASF AG (DE) | 2003-04-16 | — | — | EP | disclosed |
| EP-0773955-A1 | NEW THROMBIN INHIBITORS, THEIR PREPARATION AND USE | BASF AKTIENGESELLSCHAFT (DE) | 1997-05-21 | — | — | EP | disclosed |